Thirty-day readmissions in aneurysmal subarachnoid hemorrhage: A good metric for hospital quality?
Isaac NgRose DuPublished in: Journal of neuroscience research (2019)
Thirty-day readmission rates has been increasingly used by clinicians, hospital administrators, and policy makers as a metric for the quality of care. However, the 30-day readmission rates may be affected by other factors intrinsic to the patient and may not be a good measure of the quality of care provided by the hospital. In this review, we examined the quality of the 30-day readmissions rate as a quality metric for the quality of care provided to patients with aneurysmal subarachnoid hemorrhage (SAH). It has been shown that in this patient population, 30-day readmission rate primarily captures values, such as the number of comorbidities, disease severity, and discharge dispositions. There is little association between SAH 30-day readmission rates and mortality. However, 30-day readmissions may be reduced by increasing early discharge surveillance, providing readmission reduction programs to patients discharged to medical facilities as well as to home, and identifying patients most at risk for readmission.
Keyphrases
- healthcare
- quality improvement
- end stage renal disease
- palliative care
- public health
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- type diabetes
- mental health
- case report
- patient reported outcomes
- adverse drug
- chronic pain
- affordable care act
- cardiovascular events
- coronary artery disease